

T-cell lymphoma highlights at ASH 2022: unmet needs, clinical trial updates & future outlooks
Jan 20, 2023
Experts Kate Cwynarski and Swaminathan Iyer discuss T-cell lymphoma updates from ASH 2022, including the importance of real-world data, addressing CNS relapse, and novel treatment approaches being explored. They also highlight the potential of targeted trials and the significance of global collaborations in improving patient outcomes.
Chapters
Transcript
Episode notes